The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

Abbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Purpose: The role of vitamin K in the prevention and treatment of osteoporosis and arterial calcification is examined. Summary: Vitamin K is essential for the activation of vitamin K-dependent ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the American College of Cardiology’s Annual Scientific ...

They may show up as white spots on pelvic X-rays. Treatment may not be necessary unless they cause pain. These calcifications are common, particularly in the pelvis. They are not usually a cause ...

A significant percentage of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) demonstrate coronary artery calcification (CAC) on imaging, with variations by ANCA ...

Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...